Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ALBO | ANAB | HUMA | ||
Company | Albireo Pharma Inc | Anaptysbio Inc | Humacyte Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 44.90 | 34.34 | 7.62 | ||
High | 44.90 | 35.46 | 8.33 | ||
Low | 43.99 | 33.87 | 7.37 | ||
Last | 44.15 | 34.85 | 8.28 | ||
Change | -0.10 | +1.15 | +0.73 | ||
% Change | -0.23% | +3.41% | +9.67% | ||
Volume | 1,241,200 | 170,351 | 2,289,180 | ||
20-Day Average Volume | 635,260 | 301,423 | 4,031,152 | ||
Previous Close | 44.25 | 33.70 | 7.55 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 44.18 | 28.19 | 6.28 | ||
20-Day Raw Stochastic | 43.90% | 82.33% | 83.14% | ||
20-Day Relative Strength | 72.09% | 76.12% | 61.53% | ||
Weighted Alpha | +16.30 | +107.16 | +182.04 | ||
Today's Opinion | 88% Buy | 100% Buy | 88% Buy | ||
Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
Last Month's Opinion | 100% Buy | 32% Buy | 56% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +1.28% since 02/23/23 | +6.48% since 07/15/24 | -1.79% since 07/15/24 | ||
Low | 43.53 on 02/24/23 | 32.81 on 07/16/24 | 7.37 on 07/22/24 | ||
High | 44.90 on 03/02/23 | 37.28 on 07/19/24 | 8.99 on 07/16/24 | ||
1-Month | |||||
%Chg | -0.90% since 02/02/23 | +45.13% since 06/21/24 | +59.57% since 06/21/24 | ||
Low | 43.31 on 02/23/23 | 23.39 on 06/26/24 | 4.60 on 06/28/24 | ||
High | 45.23 on 02/03/23 | 37.28 on 07/19/24 | 8.99 on 07/16/24 | ||
3-Month | |||||
%Chg | +85.66% since 12/02/22 | +77.16% since 04/22/24 | +122.97% since 04/22/24 | ||
Low | 17.78 on 12/27/22 | 18.49 on 04/25/24 | 3.69 on 04/24/24 | ||
High | 45.23 on 02/03/23 | 37.28 on 07/19/24 | 9.97 on 05/31/24 | ||
6-Month | |||||
%Chg | +156.84% since 09/02/22 | +46.65% since 01/22/24 | +192.55% since 01/22/24 | ||
Low | 16.02 on 09/07/22 | 18.49 on 04/25/24 | 2.80 on 01/26/24 | ||
High | 45.23 on 02/03/23 | 37.28 on 07/19/24 | 9.97 on 05/31/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 913,949 | 920,650 | 899,084 | ||
Shares Outstanding, K | 20,701 | 27,319 | 119,084 | ||
Annual Sales | 40,580,000 | 17,160,000 | 0 | ||
Annual Net Income | -34,030,000 | -163,620,000 | -110,780,000 | ||
Last Quarter Sales | 9,830,000 | 7,180,000 | 0 | ||
Last Quarter Net Income | -37,800,000 | -43,940,000 | -31,900,000 | ||
60-Month Beta | 1.03 | -0.25 | 1.51 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.89 on 11/08/22 | -1.64 on 05/09/24 | -0.29 on 05/10/24 | ||
Latest Earnings Date | 03/07/23 | 08/05/24 | 08/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |